Jacob Kildevang Jensen

Jacob Kildevang Jensen is a PhD Student at the Department of Biomedical Sciences, University of Copenhagen, working within the Cluster for Molecular Imaging. His research focuses on molecular imaging techniques, particularly PET imaging applications in cardiovascular disease and inflammation quantification.

His primary research interests include cardiovascular molecular imaging, atherosclerotic inflammation, and the application of novel radiotracers in both preclinical and clinical settings. Dr. Jensen's work demonstrates expertise in PET imaging with various radiotracers including $$^{64}$$Cu-DOTATATE and $$^{68}$$Ga-NODAGA-E[(cRGDyK)]$$ _2 $$, as well as exploring therapeutic interventions like GLP-1 receptor agonists in cardiovascular disease. His research spans from technical aspects of image acquisition and analysis to clinical applications for understanding and treating cardiovascular conditions, particularly in patients with diabetes.

Analysis of his publication record reveals a strong focus on translational cardiovascular imaging research, with work spanning preclinical animal models to human clinical trials. His most cited work examines the effects of diabetes medications like semaglutide and liraglutide on vascular inflammation, demonstrating significant contributions to understanding the cardiovascular benefits of these therapies. His technical work on positron range correction in cardiac PET/CT shows his ability to address methodological challenges in molecular imaging.

Dr. Jensen is actively involved in the Cluster for Molecular Imaging at the University of Copenhagen, collaborating extensively with leading researchers including Professor Andreas Kjær and Dr. Rasmus Sejersten Ripa. His research is frequently published in high-impact journals such as Journal of Nuclear Cardiology, Atherosclerosis, and Frontiers in Endocrinology, reflecting the significance of his contributions to the field of molecular cardiovascular imaging.